Health
Newer Type 2 diabetes medications have heart and kidney disease benefits, too – Science Codex
DALLAS, Sept. 28, 2020 — Two newer groups of medications prescribed primarily for Type 2 diabetes treatment (SGLT2 inhibitors and GLP-1 receptor agonists) could significantly reduce risks associated with chronic kidney disease (CKD) and heart disease. Based on analyses of the clinical trials through March 2020, a group of leading experts in diabetes, heart failure, kidney disease and cardiometabolic disease believe the medicines should be considered for people with CKD and Type 2 diabetes to pr…
-
Noosa News23 hours agoBrisbane’s Triffid forces redesign of $1.5 billion tower project
-
General19 hours agoIsraeli forces open fire towards diplomatic delegation touring Jenin in the northern West Bank
-
General12 hours agoCharlotte McConaghy calls for climate change action in new novel Wild Dark Shore
-
General22 hours agoSussan Ley’s office says Bridget McKenzie made false claims about cabinet solidarity